Your browser doesn't support javascript.
loading
Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP).
Mitamura, T; Pradeep, S; McGuire, M; Wu, S Y; Ma, S; Hatakeyama, H; Lyons, Y A; Hisamatsu, T; Noh, K; Villar-Prados, A; Chen, X; Ivan, C; Rodriguez-Aguayo, C; Hu, W; Lopez-Berestein, G; Coleman, R L; Sood, A K.
Afiliação
  • Mitamura T; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pradeep S; Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • McGuire M; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wu SY; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Ma S; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hatakeyama H; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lyons YA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hisamatsu T; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Noh K; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Villar-Prados A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chen X; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ivan C; Gene Therapy Research Unit, Korea Research Institute of Bioscience and Biotechnology, Dajeon, Republic of Korea.
  • Rodriguez-Aguayo C; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hu W; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lopez-Berestein G; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Coleman RL; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sood AK; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Oncogene ; 37(6): 722-731, 2018 02 08.
Article em En | MEDLINE | ID: mdl-29059175
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Resistencia a Medicamentos Antineoplásicos / Fator A de Crescimento do Endotélio Vascular / Neoplasias das Tubas Uterinas / Bevacizumab / Carcinoma Epitelial do Ovário / Proteínas de Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Resistencia a Medicamentos Antineoplásicos / Fator A de Crescimento do Endotélio Vascular / Neoplasias das Tubas Uterinas / Bevacizumab / Carcinoma Epitelial do Ovário / Proteínas de Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article